XClinical executives will showcase the company’s innovations regarding products and services. Dr. Claus Lindenau will hold a lecture in the session “CDISC SDTM Data Conversion”. XClinical GmbH, Munich, Germany – June 17, 2008 – XClinical, a European vendor of innovative software products for e-clinical trials, and known for its innovative CDISC certified EDC software suite MARVIN, today announced its participation at the 44th Annual DIA Meeting to be held on June 22 to 26, 2008, in Boston, MA, USA. “The forthcoming DIA event will welcome attendees from all geographic locations, making it the perfect venue for global networking opportunities”, said Dr. Lindenau, XClinical’s head of business development. After XClinical’s successful expansion into the U.S. market last year, the company’s next step is now to further strengthen its presence in the United States. BioStat International Inc. (BSI), XClinical’s recent U.S. client,...

One of XClinical’s customers, the Munich-based CRO OSE Oncology Services Europe S.a.r.l., has just started a large clinical trial for one of Europe’s premier pharmaceutical companies. XCLINICAL GMBH, Munich, Germany – May 14, 2008 – XClinical, a European vendor of innovative software products for eClinical trials, announced the use of MARVIN, its CDISC ODM certified EDC solution, in a large European multicentric clinical trial conducted by its Munich-based customer, OSE Oncology Services Europe S.a.r.l. (OSE). The study, initiated by the subsidiary of a global pharmaceutical company, will take place in 20 countries and involves up to 160 sites. OSE, who has only recently joined XClinical’s growing customer list, and was trained on MARVIN in a very short time, is responsible for the project. MARVIN’s special ability to combine EDC (Electronic Data Capture) and DDE (Double Data Entry) was the key feature in being chosen for the mentioned...